Clinical outcome of neoadjuvant chemoradiation therapy with oxaliplatin and capecitabine or 5-fluorouracil for locally advanced rectal cancer

Journal of Surgical Oncology

Volumn 108, Issue 4, 2013, Pages 213-219

  Lu, Jun Yang ^a   Xiao, Yi ^a   Qiu, Hui Zhong ^a   Wu, Bin ^a   Lin, Guo Le ^a   Xu, Lai ^a   Zhang, Guan Nan ^a   Hu, Ke ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

combined modality therapy; pathologic response; rectal cancer; survival

Indexed keywords

CAPECITABINE; CAPECITABINE PLUS OXALIPLATIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ABDOMINAL PAIN; ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BONE MARROW SUPPRESSION; COHORT ANALYSIS; CONTINUOUS INFUSION; DIARRHEA; DISEASES; DRUG SAFETY; FEMALE; FEVER; HAND FOOT SYNDROME; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PAIN; PERIPHERAL NEUROPATHY; PREOPERATIVE PERIOD; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; RADICAL RESECTION; RASH; RECTUM CANCER; RETROSPECTIVE STUDY; SIDE EFFECT; SURVIVAL; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; VOMITING;

COMBINED MODALITY THERAPY; PATHOLOGIC RESPONSE; RECTAL CANCER; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; ORGANOPLATINUM COMPOUNDS; RECTAL NEOPLASMS; TREATMENT OUTCOME;

EID: 84882453662     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23394     Document Type: Article

References (40)

1. Sauer R, Becker H, Hohenberger W, et al.: Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
2. Bosset JF, Collette L, Calais G, et al.: Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
3. Sebag-Montefiore D, Stephens RJ, Steele R, et al.: Preoperative radiotherapy versus elective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 2009; 373: 811-820.
4. Pucciarelli S, Gagliardi G, Maretto I, et al.: Long-term oncologic results and implications after preoperative chemoradiotherapy for rectal cancer: A single-institution experience after a median follow-up of 95 months. Ann Surg Oncol 2009; 16: 893-899.
5. Kusters M, Marijnen CA, van de Velde CJ, et al.: Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010; 36: 470-476.
6. Benson AB III, Bekaii-Saab T, Chan E, et al.: Rectal cancer. J Natl Compr Cancer Netw 2012; 10: 1528-1564.
7. Kelly H, Goldberg RM:, Systemic therapy for metastatic colorectal cancer: Current options, current evidence. J Clin Oncol 2005; 23: 4553-4560.
8. Gerard JP, Azria D, Gourgou-Bourgade S, et al.: Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010; 28: 1638-1644.
9. Aschele C, Cionini L, Lonardi S, et al.: Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: Pathologic results of the STAR-01.randomized phase III trial. J Clin Oncol 2011; 29: 2773-2780.
10. Rodel C, Liersch T, Becker H, et al.: Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: Initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol 2012; 13: 679-687.
11. Stipa F, Chessin DB, Shia J, et al.: A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006; 13: 1047-1053.
12. Janjan NA, Crane C, Feig BW, et al.: Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001; 24: 107-112.
13. Pucciarelli S, Toppan P, Friso ML, et al.: Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004; 47: 1798-1807.
14. Yeo SG, Kim DY, Kim TH, et al.: Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: Long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01). Ann Surg 2010; 252: 998-1004.
15. de Campos-Lobato LF, Stocchi L, da Luz Moreira A, et al.: Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence. Ann Surg Oncol 2011; 18: 1590-1598.
16. Williams NS, Murphy J, Knowles CH:, Anterior Perineal PlanE for Ultra-low Anterior Resection of the Rectum (the APPEAR technique): A prospective clinical trial of a new procedure. Ann Surg 2008; 247: 750-758.
17. Gérard JP, Conroy T, Bonnetain F, et al.: Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD9203. J Clin Oncol 2006; 24: 4620-4625.
18. Aschele C, Friso ML, Pucciarelli S, et al.: A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol 2005; 16: 1140-1146.
19. Koeberle D, Burkhard R, von Moos R, et al.: Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. Br J Cancer 2008; 98: 1204-1209.
20. Chau I, Brown G, Cunningham D, et al.: Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 2006; 24: 668-674.
21. Machiels JP, Duck L, Honhon B, et al.: Phase II study of preoperative oxaliplatin, capecitabine and external beam radiotherapy in patients with rectal cancer: The RadiOxCape study. Ann Oncol 2005; 16: 1898-1905.
22. Carlomagno C, Farella A, Bucci L, et al.: Neo-adjuvant treatment of rectal cancer with capecitabine and oxaliplatin in combination with radiotherapy: A phase II study. Ann Oncol 2009; 20: 906-912.
23. Fernández-Martos C, Pericay C, Aparicio J, et al.: Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol 2010; 28: 859-865.
24. Roh MS, Colangelo LH, O'Connell MJ, et al.: Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009; 27: 5124-5130.
25. Roh GAY MS, O'Connell MJ, Beart RW, et al.: The impact of capecitabine and oxaliplatin in the preoperative multimodality treatment in patients with carcinoma of the rectum. J Clin Oncol 2011; 29: Abstr. 3503.
26. Fontana E, Pucci F, Camisa R, et al.: Long-term results of preoperative 5-fluorouracil-oxaliplatin chemoradiation therapy in locally advanced rectal cancer. Anticancer Res 2013; 33: 725-730.
27. Greto D, Paiar F, Saieva C, et al.: Neoadjuvant oxaliplatin and 5-fluorouracil with concurrent radiotherapy in patients with locally advanced rectal cancer: A single institution experience. Radiol Med 2013; 118: 570-582.
28. Wiig JN, Larsen SG, Dueland S, et al.: Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer. J Surg Oncol 2005; 92: 70-75.
29. Guillem JG, Chessin DB, Cohen AM, et al.: Long term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241: 829-838.
30. Capirci C, Valentini V, Cionini L, et al.: Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 2008; 72: 99-107.
31. Chan AK, Wong A, Jenken D, et al.: Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 6: 665-677.
32. Shivnani AT, Small W Jr, Stryker SJ, et al.: Preoperative chemoradiation for rectal cancer: Results of multimodality management and analysis of prognostic factors. Am J Surg 2007; 193: 389-393.
33. Valentini V, Coco C, Picciocchi A, et al.: Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002; 53: 664-674.
34. Theodoropoulos G, Wise WE, Padmanabhan A, et al.: T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002; 45: 895-903.
35. Hole KH, Larsen SG, Grøholt KK, et al.: Magnetic resonance-guided histopathology for improved accuracy of tumor response evaluation of neoadjuvant treatment in organ-infiltrating rectal cancer. Radiother Oncol 2013; 107: 178-183.
36. Kundel Y, Brenner R, Purim O, et al.: Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option ? Dis Colon Rectum 2010; 53: 1624-1631.
37. Habr-Gama A, Santinho B, de Souza PM, et al.: Low rectal cancer. Impact of radiation and chemotherapy on surgical treatment. Dis Colon Rectum 1998; 41: 1087-1096.
38. Gavioli M, Bagni A, Piccagli I, et al.: Usefulness of endorectal ultrasound after preoperative radiotherapy in rectal cancer. Dis Colon Rectum 2000; 43: 1075-1083.
39. Hiotis SP, Weber SM, Cohen AM, et al.: Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: An analysis of 488 patients. J Am Coll Surg 2002; 194: 131-136.
40. Barbaro B, Schulsinger A, Valentini V, et al.: The accuracy of transrectal ultrasound in predicting the pathological stage of low-lying rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 1999; 43: 1043-1047.